Show Filters
Hide Filters
Class (Stereo):
CHEMICAL (ACHIRAL)
Sotirimod is designed to treat actinic keratosis and other conditions and is a follow-up of Aldara (active substance: imiquimod). Sotirimod and imiquimod are immunomodulatory drugs that activate the body's immune system to combat skin changes such as... actinic keratosis. Sotirimod is immunostimulants and Toll-like receptor 7 agonist. Sotirimod was originally developed by 3M Pharmaceuticals, then licensed to Meda in Europe for the treatment of actinic keratosis in 2007. Sotirimod had been in phase III development for the treatment of actinic keratosis. However, there is no recent development report for this study.
